| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.1 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |